MedPath

Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals

Completed
Conditions
Ultrasound
Botulinum Toxin
Spasticity
Adults
Interventions
Drug: Botulinum toxin injection under anatomical landmark
Drug: Ultrasound-guided botulinum toxin injection
Registration Number
NCT06941883
Lead Sponsor
Tanta University
Brief Summary

This study aimed to compare the safety and outcome of ultrasound (US)- guided botulinum toxin (BoNT) injection and anatomically guided injection in muscle spasticity of different causes in adults.

Detailed Description

One of the major complications of neurological diseases is spasticity which is defined as an increased velocity-dependent muscle tone.

A large volume of clinical data has demonstrated the efficacy and safety of botulinum toxin type A (BoNT-A) products for treating conditions such as spasticity.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Age > 18 years old.
  • Both sexes.
  • Patients with muscle spasticity.
Exclusion Criteria
  • Patients with contraindications to botulinum toxin injection as allergy, myasthenia gravis, and cerebral palsy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Botulinum toxin injection under anatomical landmarkBotulinum toxin injection under anatomical landmarkPatients received botulinum toxin injections under the anatomical landmark.
Ultrasound-guided botulinum toxin injectionUltrasound-guided botulinum toxin injectionPatients received ultrasound-guided botulinum toxin injection
Primary Outcome Measures
NameTimeMethod
Assessment the range of movement6 months after the procedure

The range of movement regarding forearm pronation, thumb flexion, ankle inversion and fingers flexion according to modified Ashworth scale (MAS): score zero indicate no increase in tone, score 1 indicate slight increase in tone, catch or release at end range of motion (ROM), score 1 + indicate a slight increase in tone catch, release, resistance through rest ROM (1/2 ROM), score 2 indicate more marked increase in tone through ROM but affected part moved easily, score 3 indicate a considerable increase in tone, passive movement difficult, score 4 indicate affected part in rigid flexion and extension. It was assessed after three and six months.

Secondary Outcome Measures
NameTimeMethod
Assessment the quality of life6 months after the procedure

Patients' quality of life (QOL) was assessed before and after intervention with the World Health Organization (WHO)-QOL scale). The WHOQOL is a 26-item instrument consisting of four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains QOL and general health items. Each individual item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale. The scores are then transformed linearly to a 0-100 scale.

Trial Locations

Locations (1)

Tanta University

🇪🇬

Tanta, El-Gharbia, Egypt

© Copyright 2025. All Rights Reserved by MedPath